Filing Details
- Accession Number:
- 0001246360-12-004606
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-04 17:20:14
- Reporting Period:
- 2012-11-30
- Filing Date:
- 2012-12-04
- Accepted Time:
- 2012-12-04 17:20:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 911326 | Synageva Biopharma Corp | GEVA | Biological Products, (No Disgnostic Substances) (2836) | 561808663 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532218 | K Sanj Patel | 128 Spring Street, Suite 520 Lexington MA 02421 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-30 | 5,000 | $0.95 | 6,031 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-30 | 5,000 | $48.87 | 1,031 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-12-03 | 30,000 | $0.95 | 31,031 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-03 | 30,000 | $49.42 | 1,031 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-11-30 | 5,000 | $0.00 | 5,000 | $0.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-12-03 | 30,000 | $0.00 | 30,000 | $0.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 230,304 | 2019-07-01 | No | 4 | M | Direct | |
| 200,304 | 2019-07-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 286 | Indirect | Held by Abbey Road Investment Group |
Footnotes
- The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 8, 2011.
- The stock option granted the reporting person an option to purchase 396,070 Shares. 25% of such Shares vested and became exercisable on 07/01/2010, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
Billionaire Hedge Funds
